JP2017501999A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017501999A5 JP2017501999A5 JP2016536910A JP2016536910A JP2017501999A5 JP 2017501999 A5 JP2017501999 A5 JP 2017501999A5 JP 2016536910 A JP2016536910 A JP 2016536910A JP 2016536910 A JP2016536910 A JP 2016536910A JP 2017501999 A5 JP2017501999 A5 JP 2017501999A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- ala
- ser
- pharmaceutical composition
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361912631P | 2013-12-06 | 2013-12-06 | |
| US61/912,631 | 2013-12-06 | ||
| US201461924869P | 2014-01-08 | 2014-01-08 | |
| US61/924,869 | 2014-01-08 | ||
| PCT/IL2014/051067 WO2015083173A1 (en) | 2013-12-06 | 2014-12-07 | Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017501999A JP2017501999A (ja) | 2017-01-19 |
| JP2017501999A5 true JP2017501999A5 (enExample) | 2017-12-28 |
| JP6757667B2 JP6757667B2 (ja) | 2020-09-23 |
Family
ID=52396781
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016536910A Expired - Fee Related JP6757667B2 (ja) | 2013-12-06 | 2014-12-07 | Ｃｄ２８を介したシグナル伝達を阻害する短ペプチドによる炎症性疾病の症候の軽減 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US9963497B2 (enExample) |
| EP (1) | EP3077415B1 (enExample) |
| JP (1) | JP6757667B2 (enExample) |
| AU (2) | AU2014358677A1 (enExample) |
| CA (1) | CA2932150A1 (enExample) |
| SG (2) | SG10201804750XA (enExample) |
| WO (1) | WO2015083173A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG10201804750XA (en) * | 2013-12-06 | 2018-07-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 |
| JP2020517259A (ja) | 2017-04-19 | 2020-06-18 | ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム | 操作された抗原受容体を発現する免疫細胞 |
| CN111163792A (zh) * | 2017-10-06 | 2020-05-15 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 用于治疗病毒感染的肽 |
| JP7273421B2 (ja) | 2018-02-21 | 2023-05-15 | ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム | ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用 |
| CN111253469B (zh) * | 2020-03-06 | 2021-09-07 | 暨南大学 | 一种自组装短肽及其在治疗痤疮方面的应用 |
| US20250134947A1 (en) * | 2021-11-02 | 2025-05-01 | Enumita As | Tri-, tetra and pentapeptides, compositions thereof and their use in the therapy of psoriasis |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8535672B2 (en) * | 2002-04-04 | 2013-09-17 | Yissum Research Development Of The Hebrew University Of Jerusalem | Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between CD28 and the superantigen and uses thereof |
| AU2003272065A1 (en) * | 2003-04-03 | 2004-10-25 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Broad-spectrum in-vivo effective superantigen toxin antagonists based on the interaction between cd28 and the superantigen and uses thereof |
| US20110097339A1 (en) * | 2008-07-18 | 2011-04-28 | Domantis Limited | Compositions monovalent for CD28 binding and methods of use |
| PL2536764T3 (pl) * | 2010-02-18 | 2018-12-31 | Ose Immunotherapeutics | Humanizowane przeciwciała anty-CD28 |
| DE102012008730A1 (de) | 2011-12-02 | 2013-06-06 | Dr. Budz GmbH | Orale Zusammensetzungen mit ungesättigten C18-Fettsäuren und ihre Verwendung |
| BR112014017519A8 (pt) | 2012-01-16 | 2017-07-04 | Atox Bio Ltd | peptídeos sintéticos para tratamento de infecções bacterianas |
| SG10201804750XA (en) * | 2013-12-06 | 2018-07-30 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 |
-
2014
- 2014-12-07 SG SG10201804750XA patent/SG10201804750XA/en unknown
- 2014-12-07 EP EP14830734.1A patent/EP3077415B1/en active Active
- 2014-12-07 US US15/035,571 patent/US9963497B2/en active Active
- 2014-12-07 WO PCT/IL2014/051067 patent/WO2015083173A1/en not_active Ceased
- 2014-12-07 AU AU2014358677A patent/AU2014358677A1/en not_active Abandoned
- 2014-12-07 SG SG11201604512XA patent/SG11201604512XA/en unknown
- 2014-12-07 CA CA2932150A patent/CA2932150A1/en not_active Abandoned
- 2014-12-07 JP JP2016536910A patent/JP6757667B2/ja not_active Expired - Fee Related
-
2017
- 2017-11-14 AU AU2017261479A patent/AU2017261479B2/en not_active Ceased
-
2018
- 2018-03-27 US US15/936,686 patent/US10280209B2/en not_active Expired - Fee Related